Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Role of liver resection in treating intermediate and advanced stage adolescent and young adult hepatocellular carcinoma patients: A propensity-matching cohort study.

Zhang W, Liu C, Tan Y, Jiang L, Yan L, Yang J, Wen T.

Int J Surg. 2018 Jun;54(Pt A):259-264. doi: 10.1016/j.ijsu.2018.03.051. Epub 2018 Mar 28.

PMID:
29602016
2.

Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.

Chen RX, Gan YH, Ge NL, Chen Y, Ma H, Wang Y, Zhang BH, Wang YH, Ye SL, Luo JF, Ren ZG.

J Gastroenterol Hepatol. 2016 Feb;31(2):442-9. doi: 10.1111/jgh.13077.

PMID:
26259976
3.

Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis.

Zhu SL, Ke Y, Peng YC, Ma L, Li H, Li LQ, Zhong JH.

PLoS One. 2014 Dec 26;9(12):e115834. doi: 10.1371/journal.pone.0115834. eCollection 2014.

4.

Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis.

Guo Z, Zhong JH, Jiang JH, Zhang J, Xiang BD, Li LQ.

Ann Surg Oncol. 2014 Sep;21(9):3069-76. doi: 10.1245/s10434-014-3704-8. Epub 2014 Apr 12.

PMID:
24728740
5.

Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.

Zhong JH, Ke Y, Gong WF, Xiang BD, Ma L, Ye XP, Peng T, Xie GS, Li LQ.

Ann Surg. 2014 Aug;260(2):329-40. doi: 10.1097/SLA.0000000000000236.

PMID:
24096763
6.

Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.

Yang B, Zheng B, Yang M, Zeng Z, Yang F, Pu J, Li C, Liao Z.

Hepatol Int. 2018 Sep;12(5):417-428. doi: 10.1007/s12072-018-9888-4. Epub 2018 Aug 2.

PMID:
30073454
7.

Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.

Huang Y, Chen B, Liu N, Li N, Dao H, Chen W, Yang J.

Int J Clin Pharmacol Ther. 2017 Jun;55(6):498-508. doi: 10.5414/CP202787.

PMID:
28157070
8.

Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization.

Zhong JH, Xiang BD, Gong WF, Ke Y, Mo QG, Ma L, Liu X, Li LQ.

PLoS One. 2013 Jul 9;8(7):e68193. doi: 10.1371/journal.pone.0068193. Print 2013.

9.

Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma.

Liu PH, Hsia CY, Lee YH, Hsu CY, Huang YH, Su CW, Lee RC, Lin HC, Huo TI.

J Surg Oncol. 2015 Mar 15;111(4):404-9. doi: 10.1002/jso.23854. Epub 2015 Feb 2.

PMID:
25643842
10.

Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.

Zhang DZ, Wei XD, Wang XP.

World J Gastroenterol. 2015 Apr 21;21(15):4635-43. doi: 10.3748/wjg.v21.i15.4635.

11.

Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: A multicenter study from Japan.

Tada T, Kumada T, Toyoda H, Tsuji K, Hiraoka A, Itobayashi E, Nouso K, Kariyama K, Ishikawa T, Hirooka M, Hiasa Y.

Cancer Sci. 2017 Jul;108(7):1414-1420. doi: 10.1111/cas.13257. Epub 2017 May 23.

12.

Surgical resection versus transarterial chemoembolization for BCLC intermediate stage hepatocellular carcinoma: a systematic review and meta-analysis.

Liang L, Xing H, Zhang H, Zhong J, Li C, Lau WY, Wu M, Shen F, Yang T.

HPB (Oxford). 2018 Feb;20(2):110-119. doi: 10.1016/j.hpb.2017.10.004. Epub 2017 Nov 22.

13.

Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection?

Jianyong L, Lunan Y, Wentao W, Yong Z, Bo L, Tianfu W, Minqing X, Jiaying Y.

Medicine (Baltimore). 2014 Nov;93(26):e180. doi: 10.1097/MD.0000000000000180.

14.

Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.

Chen R, Gan Y, Ge N, Chen Y, Wang Y, Zhang B, Wang Y, Ye S, Ren Z.

J Vasc Interv Radiol. 2016 Dec;27(12):1829-1836. doi: 10.1016/j.jvir.2016.06.010. Epub 2016 Aug 21.

PMID:
27553917
15.

Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score.

Op den Winkel M, Nagel D, Op den Winkel P, Trojan J, Paprottka PM, Steib CJ, Schmidt L, Göller M, Stieber P, Göhring P, Herbst A, Rentsch M, De Toni EN, Göke B, Gerbes AL, Kolligs FT.

Eur J Gastroenterol Hepatol. 2018 Jan;30(1):44-53. doi: 10.1097/MEG.0000000000001005.

PMID:
29076939
16.

Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis.

Jiang JH, Guo Z, Lu HF, Wang XB, Yang HJ, Yang FQ, Bao SY, Zhong JH, Li LQ, Yang RR, Xiang BD.

World J Gastroenterol. 2015 Apr 21;21(15):4627-34. doi: 10.3748/wjg.v21.i15.4627.

17.

Long-term survival after surgical resection for huge hepatocellular carcinoma: comparison with transarterial chemoembolization after propensity score matching.

Min YW, Lee JH, Gwak GY, Paik YH, Lee JH, Rhee PL, Koh KC, Paik SW, Yoo BC, Choi MS.

J Gastroenterol Hepatol. 2014 May;29(5):1043-8. doi: 10.1111/jgh.12504.

PMID:
24863186
18.

Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.

Han K, Kim JH.

World J Gastroenterol. 2015 Sep 28;21(36):10327-35. doi: 10.3748/wjg.v21.i36.10327. Review.

20.

Aggressive intrahepatic therapies for synchronous hepatocellular carcinoma with pulmonary metastasis.

Hu Z, Huang P, Zhou Z, Li W, Xu J, Xu K, Wang J, Zhang H.

Clin Transl Oncol. 2018 Jun;20(6):729-739. doi: 10.1007/s12094-017-1779-y. Epub 2017 Nov 6.

PMID:
29110217

Supplemental Content

Support Center